ClinicalTrials.gg
Drug

Dalcetrapib clinical trials

studies test it
17
open now
1
in phase 3
6
first study started
2000

How each study uses dalcetrapib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the dalcetrapib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

dalcetrapib
10
Dalcetrapib (RO4607381)
3

Studies by the year they started

17 studies that test it; most in 2008 (3)

Studies that test dalcetrapib, by start year
YearStudies
20001
20021
20042
20061
20071
20083
20101
20113
20121
20161
20211
20231

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
9
Phase 3
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 0

Hoffmann-La Roche (10) · DalCor Pharmaceuticals (3) · Akros Pharma Inc. (3) · Japan Tobacco Inc. (1)

Often tested with

Tested in the same studies.

Atorvastatin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test dalcetrapib, phase 3 first.

Studies

Open first, then newest update. How each study uses dalcetrapib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Given beside what is tested · 1 — dalcetrapib is usual care or a partner of the new treatment

Codes

What other systems call dalcetrapib · ClinicalTrials.gg INT004257

  • MeSH (NLM) C411602dalcetrapibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 3D050LIQ3HDALCETRAPIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q5210285dalcetrapibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C81529DalcetrapibOne source FDA
  • DrugBank DB12181One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.